Azides

The azide group is a versatile functional group useful in both drug discovery and chemical biology. Its bioisosteric relationship with nitro groups and its electronic similarity to alkynes, provide opportunities to modulate physicochemical properties while retaining a synthetic handle for downstream transformations. In medicinal chemistry, azides are rarely retained in final drug candidates due to concerns around energetic instability and metabolic liability, but they serve as indispensable intermediates in synthetic routes, bioconjugation workflows, and prodrug strategies. The azide is also exploited in the preparation of antibody-drug conjugates, where it acts as the site-selective bioorthogonal handle for payload attachment.

The most clinically validated example of a retained azide in an approved drug is Zidovudine (Retrovir, GlaxoSmithKline), the first FDA-approved treatment for HIV infection and the first nucleoside reverse transcriptase inhibitor (NRTI). The 3'-azido group directly replaces the natural 3'-hydroxyl of thymidine, and once phosphorylated in vivo, acts as a chain terminator of viral DNA synthesis, preventing reverse transcriptase from extending the growing proviral DNA strand.

In organic synthesis, the azide group participates in several key named reactions. The Huisgen 1,3-dipolar cycloaddition with alkynes, copper-catalysed as the CuAAC reaction, is the prototypical click chemistry transformation, affording 1,4-disubstituted 1,2,3-triazoles with complete regioselectivity. The Staudinger reaction with triarylphosphines converts azides to iminophosphoranes, exploited for traceless Staudinger ligation in bioconjugation, enabling chemoselective and site-specific conjugation under mild aqueous conditions. Strain-promoted azide-alkyne cycloaddition (SPAAC), using cyclooctyne reagents, extends these capabilities to living systems where copper catalysis is not tolerated. The Curtius rearrangement converts acyl azides to isocyanates via reactive nitrene intermediates, providing a reliable route to amines, carbamates, and ureas.

Emerging synthetic techniques are rapidly expanding the utility of the azide group. In photochemistry, irradiation of organic azides generates reactive nitrene intermediates, and recent advances in visible-light photocatalysis have enabled metal-free, mild nitrene transfer to C-H bonds, affording direct C-N bond formation without prefunctionalisation of the substrate. Electrochemically, anodic oxidation of azide anions generates azidyl radicals that participate in azidooxygenation and diazidation reactions of alkenes, providing rapid access to vicinal azide-functionalised building blocks useful in synthesis. The convergence of photochemical and electrochemical activation in photoelectrochemical platforms is further broadening this space, enabling reaction manifolds inaccessible by either technique alone.